Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of ZX008 in Dravet Syndrome
NCT02823145Phase 3Completed
- Sponsor
- Zogenix, Inc.
- Start
- Jun 2016
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of fenfluramine in Dravet syndrome, sponsored by Zogenix, Inc.. Started Jun 2016; status: completed.
02
Drugs
fenfluramine
03
Conditions
Dravet syndrome
Beyond the preview
Go deeper on NCT02823145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02823145.